Ascentage Pharma Group International (AAPG) Inventory (2023 - 2026)

Ascentage Pharma Group International's Inventory history runs 3 years deep, the most recent figure standing at $4.0 million for Q4 2025.

• In Q4 2025, Inventory rose 339.34% year-over-year to $4.0 million; the TTM figure through Dec 2025 stood at $4.0 million (up 339.34% YoY), while the FY2025 annual figure was $4.1 million, up 352.65% from the prior year.
• Inventory for Q4 2025 stood at $4.0 million, up from $1.2 million in the prior quarter.
• The five-year high for Inventory was $4.0 million in Q4 2025, with the low at $918406.1 in Q4 2024.
• The 3-year median for Inventory is $1.7 million (2023), against an average of $2.1 million.
• The sharpest annual moves came in 2024 and 2025: Inventory tumbled 59.1% in 2024, then jumped 339.34% in 2025.
• Ascentage Pharma Group International's Inventory stood at $2.2 million in 2023, then sank by 59.1% to $918406.1 in 2024, then surged by 339.34% to $4.0 million in 2025.
• Business Quant data shows AAPG's Inventory at $4.0 million in Q4 2025, $1.2 million in Q2 2025, and $918406.1 in Q4 2024.